Literature DB >> 10666537

Distribution and regulation of alpha(2)-adrenoceptors in rat dorsal root ganglia.

T S Shi1, U Winzer-Serhan, F Leslie, T Hökfelt.   

Abstract

Using in situ hybridization with riboprobes the distribution of alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptor mRNAs were studied in normal rat dorsal root ganglia and after unilateral peripheral nerve injury (total nerve transection) or inflammation. The most common adrenoceptor mRNA was of the alpha(2C) subtype (almost 80% of all neuron profiles) followed by the alpha(2A) subtype (almost 20%), whereas alpha(2B)-adrenoceptor mRNA was only found in small numbers of neuron profiles. The most dramatic effect of peripheral nerve injury was observed for the alpha(2A)-adrenoceptor mRNA, which increased to 45% of all neuron profiles. In contrast, alpha(2C) adrenoceptor mRNA showed a small decrease in this situation. Carrageenan-induced peripheral inflammation did not affect the percentage of alpha(2A)- or alpha(2C)-adrenoceptor mRNA-positive profiles. These findings suggest that, if any of the alpha(2) adrenoceptor, the alpha(2A) subtype represents the most likely candidate in DRG neurons to be involved in sympathetically maintained pain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666537     DOI: 10.1016/s0304-3959(99)00224-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  29 in total

Review 1.  Complex regional pain syndromes.

Authors:  R Baron; G Wasner
Journal:  Curr Pain Headache Rep       Date:  2001-04

2.  Noradrenaline regulates substance P release from rat dorsal root ganglion neurons in vitro.

Authors:  Yan-Jie Wang; Xing-Fu Li; Feng Ding; Qiang Shu; Li-Jun Song; Xiao Yu; Hua-Xiang Liu
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

3.  [The symptom sympathetic maintained pain].

Authors:  J Schattschneider; G Wasner; A Binder; D Siebrecht; R Baron
Journal:  Schmerz       Date:  2003-10       Impact factor: 1.107

4.  Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy.

Authors:  Claudia M Campbell; Mark S Kipnes; Bruce C Stouch; Kerrie L Brady; Margaret Kelly; William K Schmidt; Karin L Petersen; Michael C Rowbotham; James N Campbell
Journal:  Pain       Date:  2012-06-08       Impact factor: 6.961

5.  [Types of topical treatment for peripheral neuropathic pain : Mechanism of action and indications].

Authors:  R Baron; F Mahn
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

6.  Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine.

Authors:  A B Malmberg; L R Hedley; J R Jasper; J C Hunter; A I Basbaum
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Does norepinephrine influence pain behavior mediated by dorsal root ganglia?: a pilot study.

Authors:  Katsumasa Tanimoto; Tsuneo Takebayashi; Takeshi Kobayashi; Noritsugu Tohse; Toshihiko Yamashita
Journal:  Clin Orthop Relat Res       Date:  2011-02-11       Impact factor: 4.176

8.  Differential expression of alpha-adrenoceptor subtypes in rat dorsal root ganglion after chronic constriction injury.

Authors:  Hong-Ju Cheng; Ke-Tao Ma; Li Li; Lei Zhao; Yang Wang; Jun-Qiang Si
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

9.  Pharmacological profile of the clonidine-induced inhibition of vasodepressor sensory outflow in pithed rats: correlation with alpha(2A/2C)-adrenoceptors.

Authors:  C M Villalón; J A Albarrán-Juárez; J Lozano-Cuenca; H H Pertz; T Görnemann; D Centurión
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

Review 10.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.